A similar increase to dACE2, we also detected for another interferon-stimulated gene, ISG56, in COVID-19 patients as compared to the non-infected individuals, in agreement with the study of Scagnolari C. et al. on oropharyngeal swabs [61], as well as an in vitro transient, slight upregulation early after SARS-CoV2 infection and subsequent decrease. This evidence concerns the gene IFIT1 and COVID-19.